Vireo Growth Inc. ( VREOF) - Key Metrics
VREOF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $4.64 | $0.19 | $0.05 | -$2.35 |
| 2026Q1 | $2.95 | -$0.56 | $0.33 | $0.03 |
| 2025Q4 | $2.98 | -$0.58 | $0.53 | $0.24 |
| 2025Q3 | $2.89 | -$0.83 | -$0.21 | -$0.67 |
| 2025Q2 | $2.58 | -$0.80 | -$0.26 | -$0.47 |
VREOF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1140.91 |
| 2026Q1 | 0% | -5.09 |
| 2025Q4 | 0% | -7.78 |
| 2025Q3 | 0% | -5.84 |
| 2025Q2 | 0% | -3.50 |
VREOF
Price: $9.03
52 week price:
Earnings Per Share: -0.16 USD
P/E Ratio: -2.60
Exchange: OQX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 363.0 million